Abstract: Total saponins of Panax notoginseng (PNS) have been shown to ameliorate renal interstitial fibrosis. Ginsenoside Rg1, a panaxatriol saponin, is one of the major active molecules from PNS. The present study was undertaken to investigate the effect of ginsenoside Rg1 on renal fibrosis in rats with unilateral ureteral obstruction (UUO). The rats were randomly divided into 3 groups: sham-operation (n=15), UUO (n=15) and UUO with ginsenoside Rg1 treatment (n=15, 50 mg per kg body weight, intraperitoneally (i.p.) injected). The rats were sacrificed on Days 7 and 14 after the surgery. Histological examination demonstrated that ginsenoside Rg1 significantly inhibited interstitial fibrosis including tubular injury as well as collagen deposition. α-smooth muscle actin (α-SMA) and E-cadherin are two markers of tubular epithelial-myofibroblast transition (TEMT). Interestingly, ginsenoside Rg1 notably decreased α-SMA expression and simultaneously enhanced E-cadherin expression. The messenger RNA (mRNA) of transforming growth factor-β1 (TGF-β1), a key mediator to regulate TEMT, in the obstructed kidney increased dramatically, but was found to decrease significantly after administration of ginsenoside Rg1. Further study showed that ginsenoside Rg1 considerably decreased the levels of both active TGF-β1 and phosphorylated Smad2 (pSmad2). Moreover, ginsenoside Rg1 substantially suppressed the expression of thrombospondin-1 (TSP-1), a cytokine which can promote the transcription of TGF-β1 mRNA and the activation of latent TGF-β1. These results suggest that ginsenoside Rg1 inhibits renal interstitial fibrosis in rats with UUO. The mechanism might be partly related to the blocking of TEMT via suppressing the expression of TSP-1.
INTRODUCTION
Renal interstitial fibrosis is the final common pathway of a wide variety of chronic kidney diseases (Liu, 2006) . It is characterized by the accumulation of extracellular matrix (ECM) components including collagens I, III, and IV, proteoglycans and fibronectin. As far as the origin of matrix-producing cells in the kidney is concerned, several possibilities exist, including activation of resident interstitial fibroblasts, migrating haematopoietic or mesenchymal stem cells from the bone marrow, periadventitial cells, and tubular epithelial-myofibroblast transition (TEMT) (Strutz and Müller, 2006) . Studies with genetic models have unambiguously illustrated that TEMT is emerging as a major pathway leading to generation of the matrix-producing cells in progressive renal fibrosis (Liu, 2004) . We have reported that transforming growth factor-β1 (TGF-β1) is a key mediator to regulate TEMT (Fan et al., 1999) . TGF-β1 and its downstream signaling molecule Smad2/3 activation play an important role in the progression of renal fibrosis . It is demonstrated that TGF-β1 is usually secreted as a latent procytokine complex that has to be activated before it can bind to its receptors. Thrombospondin-1 (TSP-1), a homeotrimeric multifunctional glycoprotein, has been identified as a major activator of TGF-β1 in experimental renal disease models and it is expressed in a number of kidney cell types, particularly in areas of tubulointerstitial injury (Yevdokimova et al., 2001; Hugo, 2003; Naito et al., 2004; Daniel et al., 2004) . Specific strategies against TSP-1, such as anti-TSP-1 antisense oligonucleotides, markedly inhibited the activation of TGF-β1 and improved interstitial fibrosis (Daniel et al., 2003) . These documents suggest that TSP-1-blocking therapies may contribute to renal interstitial fibrosis. Panax notoginseng Buck F. H. Chen (Araliaceae) is one of the most widely used traditional Chinese herbal medicines for the treatment of coronary heart disease, cardiac angina, apoplexy, and atherosclerosis in clinics (Ng, 2006) . Pharmacological studies showed that total saponins of Panax notoginseng (PNS) are the active components of this drug (Li et al., 2006) . We have reported that PNS can block TEMT and inhibit the secretion of ECM, consequently ameliorating the fibrotic process of renal interstitium (Su et al., 2005; Wang et al., 2004) . However, PNS is a compound of several saponins, and it remains unclear which components are the most effective saponins against renal fibrosis. Ginsenoside Rg1, a panaxatriol saponin, is one of the major active molecules from PNS. Distribution studies showed that, after oral or intravenous administration of PNS, ginsenoside Rg1 has a high concentration in kidney (Li et al., 2006) . Besides, it is reported that, in a rat model with infarcted myocardium, ginsenoside Rg1 significantly attenuated the development of myocardial fibrosis . In a rat model with liver cirrhosis, by decreasing the expression of tumor necrosis factor-α and reducing the secretion of phospholipase A2, ginsenoside Rg1 could also improve hepatic fibrosis (Wu et al., 2003) . The anti-fibrosis role of ginsenoside Rg1 in renal tubulointerstitial fibrosis remains to be clarified yet.
In the present study, we used the rat with unilateral ureteral obstruction (UUO), a model of renal fibrosis, to investigate the effects of ginsenoside Rg1 on renal impairment and the mechanisms involved.
MATERIALS AND METHODS

Animals
The studies were performed on male SpragueDawley (SD) rats (180~200 g) purchased from Laboratory Animal Center of Sichuan University (Chengdu, China). All rats in the study were used strictly in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Experimental design
UUO was performed using an established procedure (Morrissey and Klahr, 1998; Guo et al., 2001) . In brief, under intraperitoneal pentobarbital anesthesia, the left kidney and ureter were exposed via a flank incision. Then the left ureter was ligated with 4-0 silk at two points and cut between the ligatures in order to prevent retrograde urinary tract infection. Finally, the wound was closed in layers. Sham animals underwent identical surgical procedures, but the left ureter was simply manipulated.
Ginsenoside Rg1, whose chemical structure is shown in Fig.1 (Chan et al., 2002) from our laboratory. In addition, no adverse effect was observed at this dose). UUO and SOR groups were injected intraperitoneally once daily with normal saline of the same volume. Six rats selected randomly from each group were sacrificed on Days 7 and 14 post-surgery, and the left kidneys were removed. The kidneys were sagittally sliced, snap frozen in liquid nitrogen and kept at −80 °C. Some kidney tissue samples were then immersed in 10% (w/v) formalin for histopathological and immunohistochemical evaluation.
Histopathological examination
Tissues fixed in 10% (w/v) formalin were dehydrated in graded alcohol and embedded in paraffin. Masson's trichrome staining was performed according to the standard protocol by using a reagent kit purchased from Sigma (USA). For each section with Masson's trichrome, 10 fields were digitized and scanned at 400× magnification using imaging software (Photoshop, Adobe, San Jose, California). Using a grid superimposed on the image, the number of points overlapping the blue collagen staining was counted, and the percentage of blue collagen area in the examined tubulointerstitium was measured (Mizuguchi et al., 2004) .
Immunostaining
For immunohistochemical analysis, paraffin sections (5 mm) were deparaffinized, washed with phosphate-buffered saline (PBS) and treated with 3% (v/v) H 2 O 2 for 5 min. Sections were blocked with 10% (w/v) normal goat serum in Tris-HCl-buffered saline for 1 h and then incubated with primary antibodies, including rabbit antibodies to α-smooth muscle actin (α-SMA) (1:200, ABCAM, UK), rabbit antibodies to E-cadherin (1:200, Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse antibodies to thrombospondin-1 (TSP-1) (1:100, Neomarkers, Fremont, CA, USA) at 4 °C overnight. After washing, sections were incubated with appropriate biotinconjugated secondary immunoglobulin G, and then treated with reagents from a Vecta-Elite streptavidin-peroxidase kit (Vector Laboratories, Burlingame, CA, USA) with a benzidine substrate for color development. Sections were counterstained with diluted hematoxylin. The scores were determined as previously reported (Fu et al., 2006) . Briefly, the examined area of the tubulointerstitium was outlined, positive staining patterns were identified, and the percentage of positive area in the examined tubulointerstitium was measured. All scoring was performed in a blinded manner on coded slides.
Enzyme-linked immunosorbent assay (ELISA)
To measure the level of tissue active TGF-β1, kidney tissues were homogenized in the extraction buffer containing 20 mmol/L Tris-HCl (pH 7.5), 2 mol/L NaCl, 0.1% (w/v) Tween-80, 1 mmol/L ethylene diamine tetraacetic acid (EDTA), and 1 mmol/L phenylmethylsulfonyl fluoride, and the supernatant was removed after centrifugation at 19000×g for 20 min at 4 °C. Kidney tissue active TGF-β1 level was determined using a commercial Quantikine TGF-β1 ELISA kit in accordance with the protocol specified by the manufacturer (R & D Systems, USA).
Quantitative real-time reverse transcriptase polymerase chain reaction (RT-PCR) analysis
Total RNA was extracted using RNeasy Mini RNA Extracting Kit (QIAGEN, USA) according to the manufacturer's protocol. The yield and quality of the RNA were assessed by measuring the absorbance at 260 and 280 nm followed by electrophoresis on 1.5% (w/v) agarose gels. Total RNA (500 ng) was reverse-transcribed into complementary DNA (cDNA) with ExScript RT Reagent Kit (Perfect Real Time, Takara, Japan) according to the manufacturer's guideline. In order to accurately quantify the expression levels of α-SMA, TGF-β1, TSP-1, collagen I, and fibronectin, quantitative real-time RT-PCR with TaqMan probe technique was performed. Primers and probes of α-SMA, TGF-β1, TSP-1, collagen I, fibronectin, and the internal calibrator-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (synthesized by Sangon Biological Engineering Technology & Services Co., Shanghai, China) were listed in Table 1 . A 30 µl PCR reaction solution (10× Taq buffer 3 µl; 25 mmol/L MgCl 2 3 µl; 10 mmol/L dNTPs 1 µl; 10 µmol/L forward primer 1 µl; 10 µmol/L reverse primer 1 µl; 10 µmol/L TaqMan probe 1 µl; Taq DNA polymerase 1 U; cDNA 2 µl; diethyl pyrocarbonate (DEPC)-H 2 O 17 µl) was amplified in Roche Lightcycler (Roche Diagnostics, USA). The thermocycle of PCR reaction was as follows: after an initial denaturation at 94 °C for 2 min, 45 cycles of denaturation at 94 °C for 20 s, annealing at 54 °C for 20 s, and polymerization at 60 °C for 30 s were performed. PCR products went through agarose-gel electrophoretic analysis. During the real-time PCR process, fluorescence signal was collected during annealing steps. C t (cycle of threshold) was calculated for further statistical analysis. In order to examine the efficiency of real-time PCR, standard curves were established with serial dilution of sample RNA (500 ng; α-SMA, TGF-β1, TSP-1, collagen I, fibronectin, GAPDH, 10× dilution). Pfaffl et al.(2002) 's method was used for the analysis of real-time PCR results.
Western blot analysis
Protein from kidney tissues was extracted with RIPA (radio-immunoprecipitation assay) lysis buffer. After determination of protein concentrations, 20 μg of the protein was mixed with an equal amount of 2× sodium dodecyl sulfate (SDS) loading buffer for Western blot analysis as previously reported (Fu et al., 2006) . Briefly, samples were heated at 99 °C for 5 min and then transferred to a polyvinylidene difluoride membrane. Nonspecific binding to the membrane was blocked for 1 h at room temperature with 5% (w/v) bovine serum albumin (BSA) in Tris-HCl-buffered saline. The membranes were then incubated overnight at 4 °C with primary antibodies, including rabbit antibodies to α-SMA (1:500, AB-CAM, UK), rabbit antibodies to E-cadherin (1:500, Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse antibodies to TSP-1 (1:500, Neomarkers, Fremont, CA, USA), rabbit antibodies to phosphorylated Smad2 (pSmad2) (1:500, CST, USA) and β-actin (1:1000, Sigma, USA). After washing, the membrane was incubated with appropriate secondary immunoglobulin G-peroxidase conjugates (1:10000 dilution; KPL, USA), and developed using the enhanced chemiluminescence method. Band intensities were analyzed with Quantity One software. For quantification, the densities of α-SMA, E-cadherin, TSP-1 and pSmad2 were normalized to that of β-actin in the same sample.
Statistical analysis
All data were expressed as the mean±SEM. Statistical calculations were performed using the SPSS software (SPSS, Chicago, IL, USA). Inter-group comparisons were made by a one-way analysis of variance (ANOVA). The relationships between variables were assessed by Pearson correlation analysis. P values less than 0.05 were considered to be significant.
RESULTS
Ginsenoside Rg1 attenuated interstitial fibrosis in the obstructed kidney
It was shown by Masson's trichrome staining that there was no histological abnormality in sham-operated kidney (Fig.2a) . On Day 7, the kidneys developed a conspicuous tubulointerstitial injury consisting of tubular dilatation and atrophy, interstitial inflammation and collagen accumulation. Tubulointerstitial damage was more prominent on Day 14 (Fig.2b) . Administration of ginsenoside Rg1 markedly attenuated interstitial fibrosis and reduced the collagen accumulation on Days 7 and 14 after UUO (P>0.05 vs SOR on Day 7; P<0.05 vs SOR, P<0.05 vs UUO on Day 14) (Fig.2c, Table 2 ). Collagen I and fibronectin are two major components of the interstitial matrix. As indicated by RT-PCR analysis, collagen I and fibronectin messenger RNA (mRNA) levels were increased substantially after UUO (P<0.05 vs SOR). Ginsenoside Rg1 treatment notably decreased these changes (P<0.05 vs SOR; P<0.05 vs UUO) ( Table 2) . These results further confirm that ginsenoside Rg1 could ameliorate renal interstitial fibrosis induced by UUO.
Effect of ginsenoside Rg1 on the expressions of α-SMA and E-cadherin in the obstructed kidney
α-SMA and E-cadherin are two commonly used markers for myofibroblast cell and epithelial cell, respectively. In the UUO model, increased expression of α-SMA and simultaneously decreased expression of E-cadherin often indicated TEMT. In the present experiment, the expression of α-SMA mRNA in the obstructed kidney increased dramatically on Days 7 and 14 after UUO (P<0.05 vs SOR), but decreased significantly after administration of ginsenoside Rg1 (P>0.05 vs SOR on Day 7; P<0.05 vs SOR, P<0.05, vs UUO on Day 14) (Table 3) . Immunohistochemistry analysis indicated that the level of α-SMA in the obstructed kidney was increased obviously after UUO while the expression of E-cadherin decreased noticeably (P<0.05 vs SOR). Ginsenoside Rg1 treatment could significantly reverse these changes (Table  3 , Figs.3a and 3b, see Page 889). These results are in accordance with Western blot analyses of α-SMA and E-cadherin (Fig.4) . Taken together, these results suggest that UUO induced TEMT, which was significantly attenuated by ginsenoside Rg1.
Ginsenoside Rg1 decreased the expressions of TGF-β1 and pSmad2 in the obstructed kidney
TGF-β1 via activating Smad pathway (Smad2/3) plays an important role in the TEMT process and the pathogenesis of renal fibrosis. Therefore, in the next step of this study, the expressions of TGF-β1 and pSmad2 were investigated. On Days 7 and 14 after UUO, the expression of TGF-β1 mRNA in the obstructed kidney increased dramatically (P<0.05 vs SOR). However, administration of ginsenoside Rg1 significantly decreased the level of TGF-β1 mRNA in the obstructed kidney (P>0.05 vs SOR on Day 7; P<0.05 vs SOR, P<0.05 vs UUO on Day 14) (Table 4) . Furthermore, in the obstructed kidney, quantitative analysis by specific ELISA exhibited approximately 3.2-and 2.4-fold increases in active TGF-β1 level, respectively, on Days 7 and 14 after UUO (P<0.05 vs SOR). However, ginsenoside Rg1 administration markedly reduced the increase of active TGF-β1 level in the obstructed kidney (P<0.05 vs SOR; P<0.05 vs UUO) (Table 4) . Western blot analysis further verified that the pSmad2 was enhanced substantially on Days 7 and 14 after UUO in the obstructed kidney. However, ginsenoside Rg1 treatment significantly declined the enhancement of pSmad2 induced by UUO (Fig.4) .
Ginsenoside Rg1 reduced the expression of TSP-1 in the obstructed kidney
As indicated by RT-PCR analysis, the expression of TSP-1 mRNA in the obstructed kidney increased notably on Days 7 and 14 after UUO (P<0.05 vs SOR), but decreased significantly after administration of ginsenoside Rg1 (P>0.05 vs SOR) (Table  5) . TSP-1 protein was identified in nonobstructed kidneys in smooth muscle cells of the arterioles and arteries in rats (Fig.3c) . TSP-1 was markedly increased in obstructed kidneys in cortical tubular epithelial cells on Days 7 and 14 (Fig.3c ), but the expression was attenuated by ginsenoside Rg1 treatment (P<0.05 vs SOR; P<0.05 vs UUO) (Fig.3c , Table 5 ). These results are in accordant with Western blot analysis of TSP-1 (Fig.4) . Correlation between TSP-1 and active TGF-β1 in the obstructed kidney It was reported that antisense oligonucleotides against TSP-1 decrease the activation but not the expression of TGF-β1 in nephritic glomeruli (Daniel et al., 2003) . Therefore, we evaluated the relationship between TSP-1 and active TGF-β1 in the current study. Pearson correlation analysis indicated that there was a significant positive correlation between the expression of TSP-1 and the level of active TGF-β1 (r=0.92, P<0.05) (Fig.5) .
DISCUSSION AND CONCLUSION
Ginsenoside Rg1, a panaxatriol saponin, is one of the major active molecules from PNS. It is demonstrated that ginsenoside Rg1 can significantly attenuate the development of myocardial fibrosis as well as hepatic fibrosis Wu et al., 2003) . Ma et al.(2007) showed that in a rat model of hepatic fibrosis, panaxsaponin Rg1 protected hepatic function, degraded the levels of pCIII, HA, LN, and improved the pathological changes. Zhang and Wang (2006) demonstrated that ginsenoside Rg1 significantly inhibited the proliferation of human arterial smooth muscle cells (HASMCs) induced by tumor necrosis factor-α (TNF-α), and its antiproliferative effect involved in the inhibition of ERK and PI3K/PKB activation. These documents suggest that ginsenoside Rg1 may play a role in the prevention of tissue fibrosis. Data presented in this study indicated that ginsenoside Rg1 can potently attenuate renal Consistent with other reports (Mizuguchi et al., 2004) , after UUO, severe tubular atrophy, loss, dilation, infiltration of inflammatory cells and interstitial matrix deposition were noted. Importantly, we found that administration of ginsenoside Rg1 significantly blunted renal fibrosis induced by UUO, which included tubulointerstitial damage and collagen matrix accumulation.
Interstitial fibroblasts are the principal effector cells of renal fibrosis. Iwano et al.(2002) found that a large proportion of interstitial fibroblasts were actually originated from local TEMT during renal fibrogenesis. In the process of TEMT, tubular epithelial cells lose epithelial cell marker E-cadherin and de novo express myofibroblast cell marker α-SMA (Liu, 2004) . Selective blockade of TEMT in a mouse genetic model dramatically reduces fibrotic lesions after obstructive injury, underscoring a definite importance of TEMT in renal fibrogenesis (Yang et al., 2002) . In the present study, we demonstrated that there was a dramatic increase of α-SMA expression in the obstructed kidney after UUO. On the other hand, epithelial cell marker E-cadherin was substantially decreased in the tubular epithelium of the obstructed kidney. These data indicated that there existed marked transition from tubular epithelial cells into myofibroblasts in the obstructed kidney. Our studies confirm that administration of ginsenoside Rg1 largely decreased the expression of α-SMA and, meanwhile, increased the expression of E-cadherin. The results suggest that ginsenoside Rg1 could inhibit TEMT process in the UUO model. Previous studies from our laboratory show that PNS had an ameliorative effect on the fibrotic process of renal interstitium, and it could block TEMT in vivo (Su et al., 2005) . The present results suggest that ginsenoside Rg1 has a comparable contribution to renal fibrosis and TEMT, which may be the most effective saponin in PNS against renal fibrosis.
We and other researchers have shown that TGF-β1 is the most potent inducer capable of initiating and completing the entire TEMT course (Fan et al., 1999; Liu, 2004) , and that TGF-β1-induced TEMT appears to be primarily dependent on Smad pathway (activation of Smad2/3) (Liu, 2004; . In the present study, the drastic increases of TGF-β1 mRNA and pSmad2 were observed in the obstructed kidney, which were considerably reversed by ginsenoside Rg1 treatment. Moreover, ginsenoside Rg1 also reduced the increased level of active TGF-β1 after UUO. Taken together, these results suggest that the effect of ginsenoside Rg1 on renal fibrosis induced by UUO may be associated with the inhibition of TGF-β1 and its Smad pathway.
TGF-β1, considered as the most potent inducer of TEMT, must be activated extracellularly before it can bind to its receptors. TSP-1 has been identified as the major activator of latent TGF-β1 in vitro and in vivo (Yevdokimova et al., 2001; Hugo, 2003; Naito et al., 2004; Daniel et al., 2003; 2004) . In the present study, the levels of TSP-1 mRNA and protein in the obstructed kidney were notably increased compared with SOR, which is in agreement with observations in remnant kidney model (Hugo et al., 2002) . Correlation analysis further showed that there was a positive correlation between TSP-1 and active TGF-β1 in the obstructed kidney, supporting the concept that TSP-1 played a major role in the activation of TGF-β1. Yung et al.(2006) showed that the exogenous TSP-1 could increase TGF-β1 mRNA in a dose-dependent manner in human proximal renal tubular epithelial cells (HK-2 cells), and that TSP-1-mediated increase in TGF-β1 transcription was accompanied by increased TGF-β1 secretion and bioactivity. Our study reveals that, in the presence of ginsenoside Rg1, the increases of TGF-β1 mRNA, active TGF-β1 and TSP-1 were all suppressed. It appears reasonable to suggest that the beneficial effects of ginsenoside Rg1 in the UUO-induced renal interstitial fibrosis may be at least partly via decreasing the expression of TSP-1 and subsequently inhibiting the transcription and activation of TGF-β1. However, the exact mechanisms underlying the renoprotective effects of ginsenoside Rg1 need to be further elucidated.
In summary, we have demonstrated, to our knowledge for the first time, that ginsenoside Rg1 could inhibit renal interstitial fibrosis in rats with UUO. The beneficial effect of ginsenoside Rg1 might be related to the inhibition of TEMT via suppressing the expression of TSP-1 and then suppressing the transcription and activation of TGF-β1. Further studies are necessary to clarify the exact role of ginsenoside Rg1 on renal fibrosis.
